Work

Angiotensin (1–7) delivered orally via probiotic, but not subcutaneously, benefits the gut-brain axis in older rats

Year: 2020

Type: article

Source: GeroScience

DOI: 10.1007/s11357-020-00196-y

Authors: Thomas W. Buford, Yi Sun, Lisa M. Roberts, Anisha Banerjee, Sujitha Peramsetty, Anthony Knighton, Amrisha Verma, Drake Morgan, Gonzalo E. Torres, Qiuhong Li, Christy S. Carter

Institutions: University of Alabama at Birmingham, University of Florida, City College of New York, City University of New York

Language: English

Topic: Probiotics and Fermented Foods

Subfield: Food Science

Field: Agricultural and Biological Sciences

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Aging, National Heart, Lung, and Blood Institute, National Eye Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells, Ocular Renin Angiotensin System in Pathogenesis of Diabetic Retinopathy, ACE2 as a novel therapeutic to preserve physical function in late life, ACE2 Modulates the Bone Marrow- Gut Axis in Diabetic Retinopathy, UAB-UCSD O'Brien Center for Acute Kidney Injury Research, Interconnections among Cognition, Pain, and Physical Function in Aging., ACE2, Brain, Gut Dysbiosis in Pulmonary Hypertension, UAB Center for Clinical and Translational Science (CCTS), Comprehensive Cancer Center Support Grant, UAB Diabetes Research Center

OpenAlex ID: W3029079135

FWCI: 3.564

Cites: 79

Cited by: 35

Related to: 10